Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: The Japan Morning Surge-Target Organ Protection (J-TOP) study

Journal of Hypertension

Volumn 30, Issue 5, 2012, Pages 1015-1021

  Shimizu, Motohiro ^a,b   Ishikawa, Joji ^a   Yano, Yuichiro ^a   Hoshide, Satoshi ^a   Eguchi, Kazuo ^a   Ishikawa, Shizukiyo ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Iwakuni City Nishiki Central Hospital   (Japan)

Author keywords

ambulatory blood pressure; angiotensin receptor blockade; asleep blood pressure; brain natriuretic peptide; circadian rhythm; diuretic; hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CANDESARTAN;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PLASMA; PRIORITY JOURNAL; TARGET ORGAN;

EID: 84859888102     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328351f80b     Document Type: Article

References (38)

1. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al., Systolic hypertension in Europe trial investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546. (Pubitemid 29380290)
2. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245. (Pubitemid 40179967)
3. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005; 45:499-504. (Pubitemid 40411250)
4. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161. (Pubitemid 40946507)
5. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the pressioni arteriose monitorate e loro associazioni (pamela) study. Circulation 2005; 111:1777-1783. (Pubitemid 40525142)
6. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51:55-61. (Pubitemid 350307104)
7. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219-1229. (Pubitemid 47503300)
8. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension 2011; 57:3-10.
9. Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood pressure patterns and target organ damage: a review. Can J Cardiol 2007; 23:132-138. (Pubitemid 46655428)
10. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857. (Pubitemid 34258682)
11. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189. (Pubitemid 35388236)
12. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105:2392-2397. (Pubitemid 34556391)
13. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92:29-34.
14. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28:22-30. (Pubitemid 26231085)
15. Chatzis D, Tsioufis C, Tsiachris D, Taxiarchou E, Lalos S, Kyriakides Z, et al. Brain natriuretic peptide as an integrator of cardiovascular stiffening in hypertension. Int J Cardiol 2010; 141:291-296.
16. Paget V, Legedz L, Gaudebout N, Girerd N, Bricca G, Milon H, et al. N-terminal pro-brain natriuretic peptide: a powerful predictor of mortality in hypertension. Hypertension 2011; 57:702-709.
17. Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan morning surge-target organ protection (J-TOP) study. J Hypertens 2010; 28:1574-1583.
18. Eguchi K, Kuruvilla S, Ogedegbe G, Gerin W, Schwartz JE, Pickering TG. What is the optimal interval between successive home blood pressure readings using an automated oscillometric device? J Hypertens 2009; 27:1172-1177.
19. Imai Y, Sasaki S, Minami N, Munakata M, Hashimoto J, Sakuma H, et al. The accuracy and performance of the a&d tm 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the korotkoff sound technique. Am J Hypertens 1992; 5:719-726.
20. Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the a&d tm-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics. Blood Press Monit 1998; 3:255-260. (Pubitemid 28521776)
21. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated gfr from serum creatinine in japan.Am J Kidney Dis 2009; 53:982-992.
22. Andreadis EA, Georgiopoulos DX, Tzavara CK, Katsanou PM, Fragouli EG, Mavrokefalou EM, et al. Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure management? J Hypertens 2009; 27:425-432.
23. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26:669-676. (Pubitemid 37258652)
24. Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, Toyonaga S, et al. Use of plasma b-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers. Hypertens Res 2007; 30:651-658. (Pubitemid 47278324)
25. Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004; 44:2349-2354. (Pubitemid 39647609)
26. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47:742-748. (Pubitemid 43243094)
27. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006; 48:527-533. (Pubitemid 44843846)
28. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 2008; 52:1155-1160.
29. Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in african subjects. Hypertension 2008; 51:891-898. (Pubitemid 351654701)
30. Seo HS, Kang TS, Park S, Choi EY, Ko YG, Choi D, et al. Nondippers are associated with adverse cardiac remodeling and dysfunction (r1). Int J Cardiol 2006; 112:171-177. (Pubitemid 44353794)
31. Ivanovic BA, Tadic MV, Celic VP. To dip or not to dip? The unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens 2011.
32. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536. (Pubitemid 20055961)
33. Hermida RC, Calvo C, Ayala DE, Lopez JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 2005; 46:960-968.
34. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007; 50:715-722. (Pubitemid 47442736)
35. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 2009; 26:61-79.
36. Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, et al. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin a nephropathy treated with angiotensin II modulators. J Hypertens 2005; 23:861-865. (Pubitemid 40523286)
37. Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, et al. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin Exp Nephrol 2009; 13:300-306.
38. Mair J. Biochemistry of b-type natriuretic peptide: where are we now? Clin Chem Lab Med 2008; 46:1507-1514.